EUVIMEDEUVIMED entdecken
Crossref

SLC9A2 , suppressing by the transcription suppressor ETS1 , restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis

Jiangbo Han, Shen Li, Jiongzhe Cao, Hong Han, Bin Lu, Tao Wen, Weiguo Bian iD

Environmental Toxicology · 2024

DOI: 10.1002/tox.23963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Jiangbo Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, China. Hauptthemen laut MEDLINE: Osteosarcoma, MicroRNAs, Bone Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have shown that Solute Carrier Family 9 Member A2 (SLC9A2) could serve as a biomarker for cancer. However, its mechanism of action in osteosarcoma (OS) was still unclear. In this study, the data sets GSE154530 and GSE99671 were downloaded from the Gene Expression Omnibus (GEO) database, and 31 differentially expressed genes (DEGs) related to methylation were screened by bioinformatics analysis tools. Subsequently, SLC9A2 was screened as a candidate gene from DEGs, which was significantly downregulated in OS. CCK‐8, transwell, western blotting and Seahorse XFe24 Cell Metabolic Analyzer assays demonstrated that overexpression of SLC9A2 could constrain OS cell proliferation, invasion, and aerobic glycolysis. Dual‐luciferase reporter gene assay and chromatin immunoprecipitation (ChIP) assays indicated ETS proto‐oncogene 1 (ETS1) was a transcription suppressor of SLC9A2, and overexpression of ETS1 could promote methylation levels in specific regions of the SLC9A2 promoter. ETS1 could promote the proliferation, invasion, and aerobic glycolysis ability of OS cells, as well as tumor growth in vivo by inhibiting the expression of SLC9A2. In addition, SLC9A2, suppressing by ETS1, restrains growth and invasion of OS via inhibition of aerobic glycolysis. Thus, SLC9A2 can function as a key inhibitory factor in the aerobic glycolysis to inhibit proliferation and invasion of OS. This indicated that SLC9A2 has a potential targeted therapeutic effect on OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaMicroRNAsBone NeoplasmsHumansCell Line, TumorGlycolysisCell ProliferationCitric Acid CycleGene Expression Regulation, NeoplasticCell MovementProto-Oncogene Protein c-ets-1

Stichwörter der Autor:innen

ETS1SLC9A2aerobic glycolysisosteosarcomatranscription suppressor

Substanzen

MicroRNAsETS1 protein, humanProto-Oncogene Protein c-ets-1

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, China.
  • Department of Orthopedics, Xi'an Chang'an District Hospital, Xi'an, China.
  • Department of Anesthesiology, Xi'an Chang'an District Hospital, Xi'an, China.

ORCID-Profile: Weiguo Bian

Zitieren

APA

Han, J., Li, S., Cao, J., Han, H., Lu, B., Wen, T., & Bian, W. (2024). SLC9A2 , suppressing by the transcription suppressor ETS1 , restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis. Environmental Toxicology. https://doi.org/10.1002/tox.23963

Vancouver

Han J, Li S, Cao J, Han H, Lu B, Wen T, et al. SLC9A2 , suppressing by the transcription suppressor ETS1 , restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis. Environmental Toxicology. 2024. doi:10.1002/tox.23963

BibTeX
@article{Han2024,
  author = {Han, Jiangbo and Li, Shen and Cao, Jiongzhe and Han, Hong and Lu, Bin and Wen, Tao and Bian, Weiguo},
  title = {SLC9A2 , suppressing by the transcription suppressor ETS1 , restrains growth and invasion of osteosarcoma via inhibition of aerobic glycolysis},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.23963}
}
Kostenlos starten →